Compositions and methods for regulating collagen and smooth muscle actin expression by SERPINE2

Details for Australian Patent Application No. 2009319772 (hide)

Owner Centecor Research & Development, Inc. Five Prime Therapeutics, Inc.

Inventors Brace, Arthur; Sullivan, Kathleen; Finer, Jeffrey; Bosch, Elizabeth; Boyle, Kathleen; Wong, Brian; Pierce, Kristen; Bhawe, Kamudi; Das, Anuk; Farrell, Francis; Sivakumar, Pitchumani

Agent Pizzeys

Pub. Number AU-A-2009319772

PCT Pub. Number WO2010/062995

Priority 61/118,180 26.11.08 US

Filing date 25 November 2009

Wipo publication date 3 June 2010

International Classifications

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

A61K 38/57 (2006.01) Medicinal preparations containing peptides

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/062995 Priority application(s): WO2010/062995

23 June 2011 Alteration of Name

  The name of the applicant has been altered to Centocor Research & Development, Inc.; Five Prime Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319775-Optical fiber cable and bonding of sheath

2009319770-Light emitting diode module